A detailed history of Findell Capital Management LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Findell Capital Management LLC holds 300,000 shares of EXEL stock, worth $10.7 Million. This represents 3.92% of its overall portfolio holdings.

Number of Shares
300,000
Previous 500,000 40.0%
Holding current value
$10.7 Million
Previous $11.2 Billion 30.71%
% of portfolio
3.92%
Previous 5.42%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$21.96 - $27.6 $4.39 Million - $5.52 Million
-200,000 Reduced 40.0%
300,000 $7.79 Billion
Q2 2024

Aug 14, 2024

BUY
$20.34 - $23.73 $2.03 Million - $2.37 Million
100,000 Added 25.0%
500,000 $11.2 Billion
Q1 2024

May 15, 2024

BUY
$20.17 - $23.93 $8.07 Million - $9.57 Million
400,000 New
400,000 $9.49 Billion

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.5B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Findell Capital Management LLC Portfolio

Follow Findell Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Findell Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Findell Capital Management LLC with notifications on news.